News
Alafair Biosciences Celebrates Over 22,000 Implants of VersaWrap® Hydrogel Sheet in Patients
For the Second Year, Alafair Biosciences Makes Inc. 5000, With Three-Year Revenue Growth of 597%
Alafair Biosciences Receives Innovative Technology Contract from Vizient for VersaWrap®
Alafair Biosciences reports record-breaking 2023 business results
Alafair Biosciences Announces 12,000+ VersaWrap® Implants in Patients
Alafair Biosciences Selected to Exhibit VersaWrap at Vizient Innovative Technology Exchange
Alafair recognized as Austin’s Fast Growing Medical Device Company
Alafair Biosciences is Named a Best Place to Work by Austin Business Journal
Alafair Biosciences Announces VersaWrap® Sales Milestone
Alafair Enrolls Tenth Patient in Distal Radius Fracture Clinical Study
Alafair Enrolls First Patient in Hand Tendon Clinical Study
Eric Giza, MD, FACS Joins Alafair Biosciences Scientific & Clinical Advisory Board
Alafair Biosciences appoints John Joyoprayitno as new President and CEO
Alafair Biosciences Receives 510(k) Clearance for VersaWrap® Nerve Protector
Alafair Biosciences Announces VersaWrap® Tendon Protector Sales Milestone
Alafair Biosciences Raises Over $7.2 Million in Series B/B-1 Financing
Alafair Biosciences Launches VersaWrap Tendon Protector
Alafair Biosciences Receives FDA 510(k) Clearance for VersaWrap Tendon Protector